Atherosclerosis/plaque imaging with CMR: Difference between revisions
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
m (Mmir moved page Atherosclerosis/Plaque Imaging with CMR to Atherosclerosis/plaque imaging with CMR) |
||
| (2 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{SI}} | {{SI}} | ||
'''Editors-in-Chief:''' Eric A. Osborn, M.D., Ph.D. [mailto:eosborn@bidmc.harvard.edu] and Eli V. Gelfand, M.D. [mailto:egelfand@bidmc.harvard.edu] (Beth Israel Deaconess Medical Center, Harvard Medical School) | '''Editors-in-Chief:''' Eric A. Osborn, M.D., Ph.D. [mailto:eosborn@bidmc.harvard.edu] and Eli V. Gelfand, M.D. [mailto:egelfand@bidmc.harvard.edu] (Beth Israel Deaconess Medical Center, Harvard Medical School) | ||
| Line 68: | Line 68: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
{{mdr}} | {{mdr}} | ||
[[CME Category::Cardiology]] | |||
[[Category:Cardiology]] | |||
Latest revision as of 15:01, 27 February 2018
Editors-in-Chief: Eric A. Osborn, M.D., Ph.D. [1] and Eli V. Gelfand, M.D. [2] (Beth Israel Deaconess Medical Center, Harvard Medical School)
Introduction
Cardiovascular magnetic resonance (CMR) plaque imaging allows characterization of the biology of atherosclerotic lesions. Using multiple imaging sequences targeted to specific plaque constituents, the underlying composition of the plaque is determined including markers of remodeling and inflammation that are clinically relevant surrogates of plaque stability. With this technique, ‘vulnerable’ plaques prone to rupture are identified that predispose patients to acute coronary syndromes and stroke.
Pulse sequences
- Bright blood sequences are used for angiography
- Black blood sequences are used for vessel wall imaging
Techniques
- Identification of plaque components requires a multi-contrast approach with three weightings (T1, PD, T2) in black blood imaging and complementary bright blood imaging
- T1- and PD-weightings provide strong signal from the fibrous matrix and lipid core
- T2 aides in discriminating certain plaque tissue types but has a lower SNR and poor wall delineation
- Dynamic contrast enhancement (CE) with gadolinium allows evaluation of neovascularization and the time-dependent diffusion of contrast into the extracellular space
- Novel contrast media for molecular imaging are being developed (see Molecular imaging and related novel technologies)
- Resolution: 0.4-0.6mm in-plane, 2-3mm slice thickness
Characterization
Size
- Thickness
- Eccentricity
- Distribution
- Proximity of the necrotic core to the lumen
Fig. Simple plaque [[Image: ]] Fig. Complex plaque [[Image: ]]
Composition
- Lipid-rich / necrotic core
Fig. Lipid-rich / necrotic core [[Image: ]]
- Fibrous cap
Fig. Dense fibrous cap [[Image: ]] Fig. Loose fibrous cap [[Image: ]]
- Calcifications
- Hemorrhage
Fig. Fresh hemorrhage [[Image: ]] Fig. Old hemorrhage [[Image: ]]
Biological activity
- Cellular markers of plaque generation
Fig. [[Image: ]]
- Inflammatory reaction at the fibrous cap
Fig. [[Image: ]]
Validation
Trials
Further online resources
- Patient information about cardiac MR from the American College of Radiology.
References
<biblio> #ref1 pmid=16986119 </biblio>
Template:WikiDoc Sources Template:Mdr CME Category::Cardiology